SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-24-039440
Filing Date
2024-04-01
Accepted
2024-04-01 16:50:54
Documents
112
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-K qncx-20231231.htm   iXBRL 10-K 3764239
2 EX-10.6 qncx-ex10_6.htm EX-10.6 568462
3 EX-10.26 qncx-ex10_26.htm EX-10.26 940945
4 EX-10.27 qncx-ex10_27.htm EX-10.27 199731
5 EX-21.1 qncx-ex21_1.htm EX-21.1 10431
6 EX-23.1 qncx-ex23_1.htm EX-23.1 2685
7 EX-31.1 qncx-ex31_1.htm EX-31.1 13275
8 EX-31.2 qncx-ex31_2.htm EX-31.2 12771
9 EX-32.1 qncx-ex32_1.htm EX-32.1 10546
10 EX-32.2 qncx-ex32_2.htm EX-32.2 9850
11 EX-97.1 qncx-ex97_1.htm EX-97.1 53563
12 GRAPHIC img175013337_0.jpg GRAPHIC 551208
13 GRAPHIC img175013337_1.jpg GRAPHIC 291440
14 GRAPHIC img175013337_2.jpg GRAPHIC 261137
15 GRAPHIC img175013337_3.jpg GRAPHIC 72082
16 GRAPHIC img175013337_4.jpg GRAPHIC 37465
  Complete submission text file 0000950170-24-039440.txt   20712373

Data Files

Seq Description Document Type Size
17 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT qncx-20231231.xsd EX-101.SCH 2185034
115 EXTRACTED XBRL INSTANCE DOCUMENT qncx-20231231_htm.xml XML 3224688
Mailing Address 611 GATEWAY BLVD., SUITE 273 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BLVD., SUITE 273 SOUTH SAN FRANCISCO CA 94080 415-910-5717
Quince Therapeutics, Inc. (Filer) CIK: 0001662774 (see all company filings)

IRS No.: 901024039 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-38890 | Film No.: 24810353
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)